dc.contributor.advisor | Siam, Mohammad Kawsar Sharif | |
dc.contributor.author | Nabin, Md. Naimur Rahman | |
dc.date.accessioned | 2024-07-15T05:58:25Z | |
dc.date.available | 2024-07-15T05:58:25Z | |
dc.date.copyright | ©2024 | |
dc.date.issued | 2024-02 | |
dc.identifier.other | ID 19346041 | |
dc.identifier.uri | http://hdl.handle.net/10361/23697 | |
dc.description | This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2024. | en_US |
dc.description | Cataloged from the PDF version of thesis. | |
dc.description | Includes bibliographical references (pages 55-60). | |
dc.description.abstract | Cytomegalovirus is a virus causing irreversible neurological damage in newborns. In this study, in silico computational method was performed where, as primary protein, Capsid Vertex Component 1 Protein of cytomegalovirus from Uniprot server was selected. Using Vaxijen v2.0 it’s antigenicity (0.5142) & Cytotoxic T lymphocyte,helper T lymphocyte,B cell epitopes was found via NetCTL-1.2, NetMHCIIpan 4.0, Bepipred servers. Helper T lymphocyte epitopes were Screened via IFN, IL-4Pred & IL-10Pred epitopes. For constructing the vaccine, linkers were used. A Biochemical analysis gave potential results. With ProtParam the instability index (34.10), grand average of hydropathy (-0.263) & molecular weight (56399.91 kDa) was predicted. Using AllergenOnline & T3DB, the vaccine was discerned as non-allergen & non-toxic. ProSAweb gave Z-score (-5.95) & SWISS-MODEL generated Ramachandran plots. By C-IMMSIM, desirable responses of immune cells & antibodies in accordance with three doses of the vaccine was analyzed. In vitro, in vivo methods can be done to validate the safety & efficacy of the vaccine. | en_US |
dc.description.statementofresponsibility | Md. Naimur Rahman Nabin | |
dc.format.extent | 74 pages | |
dc.language.iso | en | en_US |
dc.publisher | Brac University | en_US |
dc.rights | Brac University theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. | |
dc.subject | Cytomegalovirus | en_US |
dc.subject | Multi-epitope vaccine | en_US |
dc.subject | Capsid vertex component 1 | en_US |
dc.subject | Biochemical analysis | en_US |
dc.subject.lcsh | Cytomegalovirus infections--Treatment | |
dc.title | In silico design of a capsid vertex component 1 protein targeted multi-epitope vaccine against cytomegalovirus | en_US |
dc.type | Thesis | en_US |
dc.contributor.department | School of Pharmacy, Brac University | |
dc.description.degree | B. Pharmacy | |